An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation. (Q53338848)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 December 2006

Language	Label	Description	Also known as
English	An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.	scientific article published on 18 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

author name string

Fan Y

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

Gélinas C

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

language of work or name

0 references

publication date

18 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

26

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

27

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

4038-4043

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210164

0 references

Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Transactivation of gene expression by nuclear and cytoplasmic rel proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Oncogenic transformation by vrel requires an amino-terminal activation domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Aberrant rel/nfkb genes and activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Tumor Necrosis Factor-α Activation of NF-κB Requires the Phosphorylation of Ser-471 in the Transactivation Domain of c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

21 January 2018

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

7 January 2021

based on heuristic

inferred from DOI database lookup

IkB-alpha-specific transcript regulation by the C-terminal end of c-Rel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210164

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210164

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/17173064

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53338848&oldid=2085746505"